Chris Markoch
Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight. Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline. Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.
by Chris Markoch
- 2023-07-19
Dividend Harvesting — also known as Dividend Capture or Ex-Div Investing — is a straight-forward strategy that allows investors to profit from volatile stock price movement around a company’s ex-dividend date.
by Chris Markoch
- 2023-07-24
One of the takeaways from the Domino’s Pizza (US:DPZ) second-quarter earnings report on Monday is that the company had “soft sales.
DPZ
UBER
PZZA
YUM
by Chris Markoch
- 2023-06-12
There are many reasons why investors will sell a stock. We’re only human after all. But there’s usually only one reason they buy a stock. And by the looks of it, there are many insiders buying Simon Property Group (US:SPG) stock. Using Fintel’s Insider Net Buyer Count Rankings, I see that SPG stock was the target of higher than usual insider buying. The stock garners an Insider Sentiment score of
SPG
REIT
by Chris Markoch
- 2023-05-31
Advance Auto Parts (US:AAP) delivered an earnings report that was a disaster by almost every measure, pulling down the entire auto parts sector as a result.
AAP
AZO
ORLY
by Chris Markoch
- 2023-05-16
Dividend harvesting is a strategy that allows an investor to capture a company’s dividend with the intention of selling the stock shortly after the stock goes ex-dividend.
LTC
THQ
THW
by Chris Markoch
- 2023-05-10
Palantir Technologies (NYSE:PLTR) stock looks set to continue its gains as Thursday’s pre-market trading takes off.
PLTR
by Chris Markoch
- 2023-05-02
Vertex Pharmaceuticals (NASDAQ:VRTX) kicked off the new month with good news in the form of its first-quarter earnings report.
VRTX
CRSP
